QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 keybanc-maintains-overweight-on-phreesia-lowers-price-target-to-32

Keybanc analyst Scott Schoenhaus maintains Phreesia (NYSE:PHR) with a Overweight and lowers the price target from $35 to $32.

 truist-securities-maintains-buy-on-phreesia-raises-price-target-to-36

Truist Securities analyst Jailendra Singh maintains Phreesia (NYSE:PHR) with a Buy and raises the price target from $35 to $36.

 jmp-securities-maintains-market-outperform-on-phreesia-raises-price-target-to-34

JMP Securities analyst Silvan Tuerkcan maintains Phreesia (NYSE:PHR) with a Market Outperform and raises the price target fr...

 canaccord-genuity-maintains-buy-on-phreesia-raises-price-target-to-38

Canaccord Genuity analyst Richard Close maintains Phreesia (NYSE:PHR) with a Buy and raises the price target from $34 to $38.

 analysts-weigh-integration-risks-as-phreesia-expands-with-new-deal

Phreesia gains analyst support with price target hikes, though integration risks and modest guidance raise tempered investor en...

 piper-sandler-maintains-overweight-on-phreesia-raises-price-target-to-34

Piper Sandler analyst Jessica Tassan maintains Phreesia (NYSE:PHR) with a Overweight and raises the price target from $33 to...

 needham-maintains-buy-on-phreesia-raises-price-target-to-35

Needham analyst Ryan MacDonald maintains Phreesia (NYSE:PHR) with a Buy and raises the price target from $29 to $35.

 phreesia-to-acquire-accessone-parent-holdings-for-aggregate-consideration-of-160m-in-cash

Phreesia, Inc. (NYSE:PHR) ("Phreesia"), a trusted leader in patient activation, today announced it has entered into a d...

 stephens--co-reiterates-overweight-on-phreesia-maintains-32-price-target

Stephens & Co. analyst Jeff Garro reiterates Phreesia (NYSE:PHR) with a Overweight and maintains $32 price target.

 phreesia-launches-voiceai-to-streamline-patient-calls-with-247-ai-powered-phone-support

New offering enhances Phreesia's existing platform, eliminating long hold times and ensuring every patient call is resolved...

 mizuho-initiates-coverage-on-phreesia-with-outperform-rating-announces-price-target-of-36

Mizuho analyst Steven Valiquette initiates coverage on Phreesia (NYSE:PHR) with a Outperform rating and announces Price Targ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION